LUDOVICA MARANDO to Leukemia, Myeloid, Acute
This is a "connection" page, showing publications LUDOVICA MARANDO has written about Leukemia, Myeloid, Acute.
Connection Strength
1.214
-
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications. Curr Oncol Rep. 2020 06 01; 22(6):61.
Score: 0.469
-
Prevalence and significance of DDX41 gene variants in the general population. Blood. 2023 10 05; 142(14):1185-1192.
Score: 0.148
-
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies. Clin Cancer Res. 2023 02 16; 29(4):711-722.
Score: 0.141
-
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression. Nat Genet. 2021 10; 53(10):1443-1455.
Score: 0.128
-
Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy. Cell Metab. 2020 11 03; 32(5):829-843.e9.
Score: 0.120
-
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. J Exp Med. 2019 04 01; 216(4):966-981.
Score: 0.108
-
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood. 2018 04 12; 131(15):1639-1653.
Score: 0.100